Ascelia Pharma News and Activities

Ascelia Pharma is a company listed under the stock ticker ACE (SE).

View the org chart displaying its 9 main executives

Most searched biographies at Ascelia Pharma

• Magnus Corfitzen, Chief Executive Officer
• Christina Sundberg, Development Project Manager
• Anton Hansson, Chief Financial Officer (until Aug 2026)

Popular executive movements at Ascelia Pharma

• Anton Hansson, Chief Financial Officer, will leave the company in Aug. 2026  (posted on July 17 2026).

Create your alert
to follow the executive moves at Ascelia Pharma.

Ascelia Pharma has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• Agenus has just announced a $340 Million fundraising (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Ascelia Pharma

• Ascelia Pharma Provides Orviglance Update – ASCELIA
• Ascelia Pharma Announces Organizational Changes and a Reduced Cost Base – ASCELIA
• Ascelia Pharma provides update on the Orviglance NDA – ASCELIA
• Ascelia Pharma Expands Orviglance IP Portfolio with New Patent Filing – ASCELIA
• Orviglance Data Presented Today at the Annual Radiology Congress ESGAR 2026 – ASCELIA
• Quarterly Report Q1 2026: Orviglance® Approaching Transformative Milestones – ASCELIA
• Bulletin from the Annual General Meeting in Ascelia Pharma AB on 4 May 2026 – ASCELIA
• Change in Number of Shares and Votes in Ascelia Pharma AB – ASCELIA
• Ascelia Pharma Carries Out a Directed Share Issue of SEK 20 Million – ASCELIA
• Annual Report 2025: Orviglance NDA submitted to the FDA, PDUFA-date set for July 2026 – ASCELIA
• View more press releases Close

Social media about Ascelia Pharma

• Ascelia Pharma on Wikipedia, Google News & Yahoo Finance
• Ascelia Pharma on LinkedIn, X (Twitter) & YouTube